Healthcare Stocks In Focus: Assessing The Outlook For 2026
Source: SeekingAlpha
2026-01-08 05:30:00 ET
After a prolonged slump, investors are giving the healthcare sector a second look as lower interest rates, potential M&A and even AI innovation help to improve the outlook. Jacky He, Vice President for Portfolio Research at TD Asset Management, joins MoneyTalk to discuss potential drivers for biotech and pharmaceutical stocks in 2026....
Read the full article on Seeking Alpha
For further details see:
Healthcare Stocks In Focus: Assessing The Outlook For 2026
Virtus LifeSci Biotech Clinical Trials
NASDAQ: BBC
BBC Trading
2.89% G/L:
$42 Last:
24,486 Volume:
$41.46 Open:
